메뉴 건너뛰기




Volumn 285, Issue 23, 2010, Pages 17693-17700

Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER; ALZHEIMER DISEASE; C-TERMINAL REGIONS; DRUG TARGETS; INSULIN-LIKE GROWTH FACTOR-I; KEY REGULATORS; NEURODEGENERATION; NEURODEGENERATIVE; NEUROTROPHIC; ORAL ADMINISTRATION; SERUM INSULIN; SRC HOMOLOGY 3 DOMAINS; THERAPEUTIC EFFICACY; TRANSMEMBRANE REGIONS; TRANSPORT MECHANISM; WILD TYPES;

EID: 77952936812     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M109.096594     Document Type: Article
Times cited : (34)

References (34)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.